Skip to main content
PMC home page
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2004 Aug;21(8):297–300. doi: 10.1023/B:JARG.0000043703.73207.25

Exposure of Preimplantation Embryos to Platelet-Activating Factor Increases Birth Rate

William E Roudebush 1, Joe B Massey 1, Hilton I Kort 1, Carlene W Elsner 1, Andrew A Toledo 1, Dorothy Mitchell-Leef 1, Daniel B Shapiro 1
PMCID: PMC3455438  PMID: 15568330

Abstract

Problem: Platelet-activating factor (PAF) plays a significant role in fertility. Preimplantation stage embryos produce PAF (ePAF) which is required for development. PAF's mechanism of action is receptor-mediated and its presence has been reported in the developing mouse and human embryo. Exposure of preimplantation stage mouse embryos results in higher implantation rates. However, the effect of such treatment on live-birth rates and birth weights has not been reported. Therefore, the objective the study was to determine the effect of exposing preimplantation mouse embryos to PAF on subsequent birth rate and weight.

Design: Two-cell stage preimplantation stage mouse embryos exposed to PAF (10−7 M) for 15 min prior to intraoviductal transfer.

Methods: Preimplantation stage embryos were recovered from eCG/hCG primed BDF1 female mice. Embryos were exposed to synthetic PAF (10−7 M) for 15 min. PAF-treated embryos were transferred to the oviducts of pseudopregnant female CD-1 female mice. Superovulated and cultured BDF1 embryos not treated with PAF served as in vitro controls and naturally ovulated embryos with no collection/culture served as in vivo controls. Embryos were permitted to develop to term (18–21 days). The number of pups born per litter and litter weights subsequently were recorded.

Results: A total of 160 BDF1 mouse embryos were collected, treated, and transferred (20 per CD-1 recipient) as described. There was a significant (P<0.05) increase in the number of pups born to the PAF treatment group (56/80; 70%) as compared to the control group (44/80; 55%). There was also a significant difference (P<0.05) in litter birth weights between the PAF (1.31 g/litter) and controls groups (1.25 g/litter). There was a significant difference (P<0.05) in birth weights between the PAF treatment group and the in vivo group (1.51 g/litter). There was a significant difference in birth weights between the in vitro control and in vivo groups (1.51 g/litter). There were no observational malformaties to pups born in any group.

Conclusions: Brief exposure of preimplantation stage embryos to PAF will result in a significant increase of delivery rates (pups/litter) as well as birth weights. However, the increase of birth weight was significantly below that found naturally. Additional studies are warranted to elucidate the mechanism of PAF's action in the preimplantation stage embryo and subsequent uterine development.

Keywords: Mouse, embryo, platelet-activating factor, term development

Full Text

The Full Text of this article is available as a PDF (109.8 KB).

REFERENCES

  • 1.O'Neill C. Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. Biol Re-prod. 1998;58:1303–1309. doi: 10.1095/biolreprod58.5.1303. [DOI] [PubMed] [Google Scholar]
  • 2.Angle MJ, Jones MA, McManus LM, Pinckard RN, Harper MJK. Platelet activating factor in the rabbit uterus during early pregnancy. J Reprod Fertil. 1988;83:711–722. doi: 10.1530/jrf.0.0830711. [DOI] [PubMed] [Google Scholar]
  • 3.Minhas BS, Zhu YP, Kim HN, Burwinkel TH, Ripps BA, Buster JE. Embryonic platelet activating factor production in the rabbit increases during the preimplantation phase. J Assist Reprod Genet. 1993;10:366–370. doi: 10.1007/BF01213432. [DOI] [PubMed] [Google Scholar]
  • 4.O'Neill C, Gidley-Baird AA, Pike IL, Saunders DM. Use of a bioassay for embryo-derived platelet-activating factor as a means of assessing quality and pregnancy potential of human embryos. Fertil Steril. 1987;47:969–975. doi: 10.1016/s0015-0282(16)59231-0. [DOI] [PubMed] [Google Scholar]
  • 5.Nakatsuka M, Yoshida N, Kudo T. Platelet activating factor in culture media as an indicator of human embryonic development after in vitro fertilization. Hum Reprod. 1992;7:1435–1439. doi: 10.1093/oxfordjournals.humrep.a137590. [DOI] [PubMed] [Google Scholar]
  • 6.Roudebush WE, Wininger JD, Jones AE, Wright G, Toledo AA, Shapiro DB, Kort HI, Massey JB. Embryonic platelet-activating factor: An indicator of embryo viability. Hum Re-prod. 2002;17(5):1306–1310. doi: 10.1093/humrep/17.5.1306. [DOI] [PubMed] [Google Scholar]
  • 7.Roberts C, O'Neill C, Wright L. Platelet-activating factor (PAF) enhances mitosis in preimplantation mouse embryos. Reprod Fertil Dev. 1993;5:271–279. doi: 10.1071/rd9930271. [DOI] [PubMed] [Google Scholar]
  • 8.Ryan JP, O'Neill C, Ammit AJ, Roberts CG. Metabolic and developmental responses of preimplantation embryos to platelet activating factor. Reprod Fertil Dev. 1992;4:3873–3898. doi: 10.1071/rd9920387. [DOI] [PubMed] [Google Scholar]
  • 9.Roudebush WE, Mathur S, Butler WJ. AntiPAF antibody inhibits CFW mouse preimplantation embryo development. J Assist Reprod Genet. 1995;11:414–418. doi: 10.1007/BF02211729. [DOI] [PubMed] [Google Scholar]
  • 10.Ishii S, Matsuda Y, Nakamura M, Waga I, Kume K, Izumi T, Shimizu T. A murine PAF receptor gene: Cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem J. 1996;314:671–678. doi: 10.1042/bj3140671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Roudebush WE, LaMarche MD, Levine AS, Jiang HH, Butler WJ. Evidence for the presence of the platelet-activating factor-receptor in the CFWmouse preimplantation two-cell stage embryo. Biol Reprod. 1997;57:575–579. doi: 10.1095/biolreprod57.3.575. [DOI] [PubMed] [Google Scholar]
  • 12.Stojanov T, O'Neill CO. Ontogeny of expression of a receptor for platelet-activating factor in mouse preimplantation embryos and the effects of fertilization and culture in vitro on its expression. Biol Reprod. 1999;60:674–682. doi: 10.1095/biolreprod60.3.674. [DOI] [PubMed] [Google Scholar]
  • 13.Ishii I, Saito E, Izumi T, Ui M, Shimuzu T. Agonist-induced se-questration, recycling, and resensitization of platelet-activating factor receptor. J Biol Chem. 1998;16:9878–9885. doi: 10.1074/jbc.273.16.9878. [DOI] [PubMed] [Google Scholar]
  • 14.Roudebush WE, Duralia DR, Butler WJ. Effect of platelet activating factor on preimplantation mouse B6D2F1/J embryo formation. Am J Reprod Immunol. 1996;35:272–276. doi: 10.1111/j.1600-0897.1996.tb00044.x. [DOI] [PubMed] [Google Scholar]
  • 15.Radjonic Lazovic G, Roudebush WE. The effect of short-vs. long-term platelet-activating exposure on murine preimplantation embryo development. Early Preg: Biol Med. 1995;1:196–200. [PubMed] [Google Scholar]
  • 16.Stoddart NR, Roudebush WE, Fleming SD. Exogenous PAF stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific effects. Zygote. 2001;9(3):261–268. doi: 10.1017/s0967199401001289. [DOI] [PubMed] [Google Scholar]
  • 17.Nishi O, Tominaga T, Goto Y, Hayashi K, Mori T. Effects of platelet activating factor on mouse embryo implantation in vitro. J Assist Reprod Genet. 1995;12(5):330–334. doi: 10.1007/BF02213714. [DOI] [PubMed] [Google Scholar]
  • 18.O'Neill C. Partial characterization of the embryo-derived platelet activating factor in mice. J Reprod Fertil. 1985;75:375–380. doi: 10.1530/jrf.0.0750375. [DOI] [PubMed] [Google Scholar]
  • 19.Collier M, O'Neill C, Ammitt AJ, Saunders DM. Biochemical and pharmacological characterization of human embryo-derived activating factor. Hum Reprod. 1988;3:993–998. doi: 10.1093/oxfordjournals.humrep.a136830. [DOI] [PubMed] [Google Scholar]
  • 20.Ryan JP, Spinks NR, O'Neill C, Saunders DM, Wales RG. Enhanced rates of implantation and increased metabolism of mouse embryos in the presence of platelet-activating factor. Proc Fertil Soc Aust. 1987;6:47. [Google Scholar]
  • 21.Ryan JP, Spinks NR, O'Neill C, Ammit AJ, Wales RG. Platelet-activating factor (PAF) production by mouse embryos in vitro and its effect on embryonic metabolism. J Cell Biochem. 1989;40:387–395. doi: 10.1002/jcb.240400314. [DOI] [PubMed] [Google Scholar]
  • 22.Ryan JP, O'Neill C, Wales RG. PAF directly influences the oxidative metabolism of glucose and lactate in the preimplantation mouse embryo. J Reprod Fertil. 1990;89:301–307. doi: 10.1530/jrf.0.0890301. [DOI] [PubMed] [Google Scholar]
  • 23.Spinks NR, O'Neill C. Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos. J Reprod Fertil. 1988;84:89–98. doi: 10.1530/jrf.0.0840089. [DOI] [PubMed] [Google Scholar]
  • 24.Andu M, Suginami H, Matsuura S. Pregnancy suppression by a structurally related antagonist for platelet-activating factor. Asia Oceania J Obstet Gyn. 1990;16:283–290. doi: 10.1111/j.1447-0756.1990.tb00239.x. [DOI] [PubMed] [Google Scholar]
  • 25.Roudebush WE, Purnell ET, Stoddart NR, Fleming SD. Embryonic-platelet-activating factor: temporal expression of the ligand and its receptor. J Assist Reprod Genet. 2002;19(2):72–78. doi: 10.1023/A:1014443630722. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES